Antifungal resistance and poor clinical outcome rates of Candida auris in mainland China: A systematic review and meta-analysis. (PubMed, Front Microbiol) - Sep 16, 2026 - "The resistance rates of caspofungin, micafungin, and anidulafungin were 3% (95%CI: 0%-11%), 2% (95%CI: 0%-4%), and 1% (95%CI: 0%-3%), respectively...Fluconazole is not an appropriate choice for treating C. auris strains in mainland China, while echinocandins should be the primary treatment option...Patients with C. auris colonization or infection exhibit variable clinical outcomes. Clinical practice should prioritize routine laboratory antifungal susceptibility surveillance, standardized hospital infection control measures, and targeted interventions to improve patient clinical outcomes."
Clinical data • Journal • Retrospective data • Review • Infectious Disease
|
|
Lei Yang; Rui Wang; Tao Xu; Yufang Gao
|